Long-Term Follow-Up of Hospitalized Dengue and Safety in Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2019
Price : $35 *
At a glance
- Drugs CYD TDV (Primary) ; Rabies vaccine
- Indications Dengue
- Focus Therapeutic Use
- Sponsors Sanofi
- 13 Jun 2018 Results of post-hoc analysis assessing effect of dengue serostatus on vaccine safety and efficacy by using data from four trials including this trial published in the New England Journal of Medicine.
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.
- 15 Jan 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov record.